No Data
Express News | Pfizer has reached a cooperation agreement with Zai Lab for a new antibacterial drug in mainland China.
Express News | Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug Xacduro® (Sulbactam-Durlobactam)
China ADRs Have Increased to the Largest Share Since Late 2021 – GS
Zai Lab Grants Share Units to Employees
Zai Lab (09688.HK) awarded 0.015 million restricted stock units (in terms of American Depositary Shares).
Gelonghui November 19th | zai lab (09688.HK) announced that on the grant date, the company granted 0.015 million restricted stock units (in the form of American depositary shares) to 8 grantees in accordance with the 2024 stock-based incentive plan terms.
zai lab (09688.HK) received shareholding of 10.125 million H shares from Wellington Management, worth approximately 0.282 billion US dollars.
Reported on November 19th, according to the documents disclosed by the Hong Kong Stock Exchange on November 19th, Wellington Management Group LLP increased its shareholding in Zai Lab (09688.HK) by $10.125 million H Shares at an average price of $27.803 per share on November 15, with a total value of approximately $0.282 billion. After the increase, Wellington Management Group's latest shareholding is 0.101 billion shares, and the holding ratio has increased from 9.14% to 10.15%. Image Source: Stock Exchange Equity Disclosure Why did the acquirer increase their stockholding.
No Data
No Data